Statins regulate the functions of T and B lymphocytes, dendritic cells, natural killer cells, reduce the production of inflammatory markers (CRP, TNF, IL-1, IL-6) and reduce the incidence of major cardiovascular events in patients with elevated high-sensitivity CRP levels but without hyperlipidemia [83–85]. The gene discussed is CRP; the disease is hyperlipidemia.